Colleen Nappi, NP

NPI: 1407100308
Total Payments
$26,072
2024 Payments
$7,504
Companies
28
Transactions
709
Medicare Patients
692
Medicare Billing
$49,310

Payment Breakdown by Category

Food & Beverage$13,096 (50.2%)
Other$10,235 (39.3%)
Travel$2,700 (10.4%)
Gifts$34.58 (0.1%)
Education$6.61 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $13,096 691 50.2%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $6,985 5 26.8%
Honoraria $3,250 2 12.5%
Travel and Lodging $2,700 8 10.4%
Gift $34.58 2 0.1%
Education $6.61 1 0.0%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $9,904 185 $0 (2024)
QOL Medical, LLC $7,618 52 $0 (2024)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $1,772 119 $0 (2024)
Janssen Biotech, Inc. $1,409 69 $0 (2024)
Takeda Pharmaceuticals U.S.A., Inc. $892.06 52 $0 (2024)
Celgene Corporation $612.27 65 $0 (2024)
NESTLE HEALTHCARE NUTRITION INC. $608.74 24 $0 (2023)
Ferring Pharmaceuticals Inc. $608.54 55 $0 (2023)
GENZYME CORPORATION $356.25 12 $0 (2024)
Pacira Pharmaceuticals Incorporated $305.69 3 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $7,504 159 QOL Medical, LLC ($4,326)
2023 $7,442 158 ABBVIE INC. ($4,765)
2022 $7,277 200 QOL Medical, LLC ($2,875)
2021 $3,849 192 AbbVie Inc. ($1,488)

All Payment Transactions

709 individual payment records from CMS Open Payments — Page 1 of 29

Date Company Product Nature Form Amount Type
12/19/2024 ABBVIE INC. LINZESS (Drug), CREON Food and Beverage In-kind items and services $28.10 General
Category: GASTROENTEROLOGY
12/18/2024 Madrigal Pharmaceuticals RESMETIROM (Drug) Food and Beverage In-kind items and services $15.96 General
Category: LIVER DISEASE
12/18/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $11.98 General
Category: GASTROENTEROLOGY
12/13/2024 Ardelyx, Inc. IBSRELA (Drug) Food and Beverage In-kind items and services $21.93 General
Category: GASTROENTEROLOGY
12/13/2024 ABBVIE INC. LINZESS (Drug), CREON Food and Beverage In-kind items and services $8.84 General
Category: GASTROENTEROLOGY
12/12/2024 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Food and Beverage In-kind items and services $19.34 General
Category: INTERNAL MEDICINE
12/11/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $17.39 General
Category: Immunology
12/04/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $15.26 General
Category: IMMUNOLOGY
12/04/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $0.99 General
Category: IMMUNOLOGY
11/21/2024 ABBVIE INC. Food and Beverage In-kind items and services $34.69 General
11/21/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $21.40 General
Category: Immunology
11/20/2024 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Food and Beverage In-kind items and services $18.15 General
Category: INTERNAL MEDICINE
11/20/2024 Madrigal Pharmaceuticals RESMETIROM (Drug) Food and Beverage In-kind items and services $15.80 General
Category: LIVER DISEASE
11/19/2024 Lilly USA, LLC OMVOH (Drug) Food and Beverage In-kind items and services $25.49 General
Category: Immunology
11/15/2024 IRONWOOD PHARMACEUTICALS, INC Linzess (Drug) Food and Beverage Cash or cash equivalent $17.72 General
Category: GI
11/12/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $25.90 General
Category: IMMUNOLOGY
11/12/2024 ABBVIE INC. LINZESS (Drug), CREON Food and Beverage In-kind items and services $11.60 General
Category: GASTROENTEROLOGY
11/12/2024 ABBVIE INC. SKYRIZI (Biological) Food and Beverage In-kind items and services $2.21 General
Category: IMMUNOLOGY
11/08/2024 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Food and Beverage In-kind items and services $20.18 General
Category: INTERNAL MEDICINE
11/08/2024 QOL Medical, LLC SUCRAID (Drug) Food and Beverage Cash or cash equivalent $4.72 General
Category: THERAPY FOR CSID
11/07/2024 ABBVIE INC. RINVOQ (Biological) Food and Beverage In-kind items and services $121.34 General
Category: IMMUNOLOGY
11/07/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $24.83 General
11/06/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $24.47 General
Category: Gastroenterology
11/06/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $17.09 General
Category: Immunology
10/30/2024 ABBVIE INC. LINZESS (Drug), CREON Food and Beverage In-kind items and services $5.39 General
Category: GASTROENTEROLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 4 286 288 $93,375 $19,697
2022 4 274 282 $87,300 $19,013
2021 4 132 135 $38,350 $10,600
Total Patients
692
Total Services
705
Medicare Billing
$49,310
Procedure Codes
12

All Medicare Procedures & Services

12 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 108 109 $32,700 $8,465 25.9%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 51 51 $19,125 $4,764 24.9%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 85 86 $25,800 $4,625 17.9%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 42 42 $15,750 $1,843 11.7%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 100 107 $29,400 $5,714 19.4%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 43 43 $15,300 $4,656 30.4%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 54 55 $16,500 $4,553 27.6%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2022 77 77 $26,100 $4,090 15.7%
99203 New patient outpatient visit, total time 30-44 minutes Office 2021 42 42 $12,600 $3,226 25.6%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 30 31 $9,300 $2,700 29.0%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 41 43 $10,750 $2,494 23.2%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 19 19 $5,700 $2,180 38.3%

About Colleen Nappi, NP

Colleen Nappi, NP is a Family healthcare provider based in Winchester, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/31/2012. The National Provider Identifier (NPI) number assigned to this provider is 1407100308.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Colleen Nappi, NP has received a total of $26,072 in payments from pharmaceutical and medical device companies, with $7,504 received in 2024. These payments were reported across 709 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($13,096).

As a Medicare-enrolled provider, Nappi has provided services to 692 Medicare beneficiaries, totaling 705 services with total Medicare billing of $49,310. Data is available for 3 years (2021–2023), covering 12 distinct procedure/service records.

Practice Information

  • Specialty Family
  • Location Winchester, VA
  • Active Since 10/31/2012
  • Last Updated 09/02/2025
  • Taxonomy Code 363LF0000X
  • Entity Type Individual
  • NPI Number 1407100308

Products in Payments

  • SUCRAID (Drug) $7,377
  • LINZESS (Drug) $7,020
  • XIFAXAN (Drug) $1,413
  • STELARA (Biological) $1,365
  • ZEPOSIA (Drug) $806.16
  • RINVOQ (Biological) $738.38
  • ZENPEP (Drug) $589.80
  • ENTYVIO (Biological) $581.31
  • HUMIRA (Biological) $543.03
  • CREON (Drug) $504.51
  • DUPIXENT (Biological) $451.29
  • TRULANCE (Drug) $359.07
  • SKYRIZI (Biological) $356.16
  • CIMZIA (Drug) $311.85
  • REBYOTA (Biological) $296.69
  • MAVYRET (Drug) $276.34
  • TREMFYA (Drug) $263.84
  • Sucraid (Drug) $240.87
  • XELJANZ (Drug) $230.42
  • VRAYLAR (Drug) $227.99

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Doctors in Winchester